The effect of interruption of the bronchial circulation and the addition of cortisone and low molecular weight dextran to blood perfusate during pulmonary perfusion in dogs.
D000818:Animals; D003348:Cortisone / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D004285:Dogs; D004417:Dyspnea / Q000209:etiology; D004903:Erythrocyte Aggregation / Q000517:prevention & control*; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D006470:Hemorrhage / Q000209:etiology; D066298:In Vitro Techniques; D008168:Lung / Q000473:pathology; D008171:Lung Diseases / Q000209:etiology*; D010477:Perfusion / Q000009:adverse effects*; D001261:Pulmonary Atelectasis / Q000209:etiology; D011652:Pulmonary Circulation; D011654:Pulmonary Edema / Q000209:etiology; D012129:Respiratory Function Tests
D003911:Dextrans; D003348:Cortisone